In a nested case-control analysis performed with use of the French national health care insurance system (SNDS) database, Julien Bezin et al (2023), compared individuals with T2D, but not on GLP1-RA with those on GLP1-RA (10)
It proposes that stimulation of GLP-1 receptors enhances the activity of dopaminergic neurons in the ventral tegmental area (VTA) through a presynaptic mechanism 42
The timeline varies by tissue type and individual, but four to six weeks appears sufficient based on the pharmacokinetic clearance data and general GPCR biology
[28] Your GP can arrange appropriate investigations including HbA1c, fasting glucose, and lipid profiles to assess your metabolic health and determine whether medical intervention is appropriate
Public Relations and Transparency Efforts: To manage public perception, Novo Nordisk has engaged in transparent communication about ongoing research, updates to drug information, and responses to regulatory inquiries
Moore, Edie, Abram